MiR-133: A Suppressor of Cardiac Remodeling?

Overview

Journal Front Pharmacol

Date 2018 Sep 4

PMID 30174600

Citations 66

Authors

Ning Li

Heng Zhou

Qizhu Tang

Affiliations

Soon will be listed here.

Abstract

Cardiac remodeling, which is characterized by mechanical and electrical remodeling, is a significant pathophysiological process involved in almost all forms of heart diseases. MicroRNAs (miRNAs) are a group of non-coding RNAs of 20-25 nucleotides in length that primarily regulate gene expression by promoting mRNA degradation or post-transcriptional repression in a sequence-specific manner. Three miR-133 genes have been identified in the human genome, miR-133a-1, miR-133a-2, and miR-133b, which are located on chromosomes 18, 20, and 6, respectively. These miRNAs are mainly expressed in muscle tissues and appear to repress the expression of non-muscle genes. Based on accumulating evidence, miR-133 participates in the proliferation, differentiation, survival, hypertrophic growth, and electrical conduction of cardiac cells, which are essential for cardiac fibrosis, cardiac hypertrophy, and arrhythmia. Nevertheless, the roles of miR-133 in cardiac remodeling are ambiguous, and the mechanisms are also sophisticated, involving many target genes and signaling pathways, such as RhoA, MAPK, TGFβ/Smad, and PI3K/Akt. Therefore, in this review, we summarize the critical roles of miR-133 and its potential mechanisms in cardiac remodeling.

Citing Articles

Myocardial ferroptosis may exacerbate the progression of atrial fibrillation through isolevuglandins.

Yue Z, Li X, Shi Z, Li X Eur J Med Res. 2025; 30(1):93.

PMID: 39940048 PMC: 11823066. DOI: 10.1186/s40001-025-02302-2.

In vivo and in silico study of europinidin against streptozotocin-isoproterenol-induced myocardial damage via alteration of hs-CRP/CPK-MB/Caspase-3/Bcl-2 pathways.

Alharbi K, Afzal M, Al-Abbasi F, Moglad E, Al-Qahtani S, Almalki N Sci Rep. 2025; 15(1):3076.

PMID: 39856142 PMC: 11761472. DOI: 10.1038/s41598-024-83900-8.

Integrated analysis of long non‑coding RNA megacluster, microRNA‑132 and microRNA‑133a and their implications for cardiovascular risk and kidney failure progression in diabetic patients.

AbdElgayed G, Hosni A, Abdel-Moneim A, Malik A, Zaky M, Hasona N Exp Ther Med. 2025; 29(2):35.

PMID: 39776891 PMC: 11705225. DOI: 10.3892/etm.2024.12785.

Regulation of idiopathic pulmonary fibrosis: a cross-talk between TGF- signaling and MicroRNAs.

Wang S, Yu H, Liu S, Liu Y, Gu X Front Med (Lausanne). 2024; 11:1415278.

PMID: 39386739 PMC: 11461268. DOI: 10.3389/fmed.2024.1415278.

Exploring miRNA therapies and gut microbiome-enhanced CAR-T cells: advancing frontiers in glioblastoma stem cell targeting.

Sandhanam K, Tamilanban T, Bhattacharjee B, Manasa K Naunyn Schmiedebergs Arch Pharmacol. 2024; .

PMID: 39382681 DOI: 10.1007/s00210-024-03479-9.

References

Konno T, Chen D, Wang L, Wakimoto H, Teekakirikul P, Nayor M . Heterogeneous myocyte enhancer factor-2 (Mef2) activation in myocytes predicts focal scarring in hypertrophic cardiomyopathy. Proc Natl Acad Sci U S A. 2010; 107(42):18097-102. PMC: 2964244. DOI: 10.1073/pnas.1012826107. View

Priya R, Liang X, Teo J, Duszyc K, Yap A, Gomez G . ROCK1 but not ROCK2 contributes to RhoA signaling and NMIIA-mediated contractility at the epithelial zonula adherens. Mol Biol Cell. 2016; 28(1):12-20. PMC: 5221615. DOI: 10.1091/mbc.E16-04-0262. View

Lee A, Chen W, Chan H, Chung C, Peng H, Chang C . Electronegative LDL-mediated cardiac electrical remodeling in a rat model of chronic kidney disease. Sci Rep. 2017; 7:40676. PMC: 5240592. DOI: 10.1038/srep40676. View

Na W, Peng G, Jianping Z, Yanzhong C, Shengjiang G, Li C . RhoA/ROCK may involve in cardiac hypertrophy induced by experimental hyperthyroidism. Toxicol Ind Health. 2011; 28(9):831-9. DOI: 10.1177/0748233711425069. View

Hong Y, Cao H, Wang Q, Ye J, Sui L, Feng J . MiR-22 may Suppress Fibrogenesis by Targeting TGFβR I in Cardiac Fibroblasts. Cell Physiol Biochem. 2016; 40(6):1345-1353. DOI: 10.1159/000453187. View

Trajkovski M, Ahmed K, Esau C, Stoffel M . MyomiR-133 regulates brown fat differentiation through Prdm16. Nat Cell Biol. 2012; 14(12):1330-5. DOI: 10.1038/ncb2612. View

Dong D, Chen C, Huo R, Wang N, Li Z, Tu Y . Reciprocal repression between microRNA-133 and calcineurin regulates cardiac hypertrophy: a novel mechanism for progressive cardiac hypertrophy. Hypertension. 2010; 55(4):946-52. DOI: 10.1161/HYPERTENSIONAHA.109.139519. View

Qin W, Dong P, Ma C, Mitchelson K, Deng T, Zhang L . MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways. Oncogene. 2011; 31(36):4067-75. DOI: 10.1038/onc.2011.561. View

John B, Stiles M, Kuklik P, Chandy S, Young G, Mackenzie L . Electrical remodelling of the left and right atria due to rheumatic mitral stenosis. Eur Heart J. 2008; 29(18):2234-43. DOI: 10.1093/eurheartj/ehn329. View

10.

Fukasawa H, Yamamoto T, Suzuki H, Togawa A, Ohashi N, Fujigaki Y . Treatment with anti-TGF-beta antibody ameliorates chronic progressive nephritis by inhibiting Smad/TGF-beta signaling. Kidney Int. 2003; 65(1):63-74. DOI: 10.1111/j.1523-1755.2004.00393.x. View

11.

Williams S, Golden-Mason L, Ferguson B, Schuetze K, Cavasin M, Demos-Davies K . Class I HDACs regulate angiotensin II-dependent cardiac fibrosis via fibroblasts and circulating fibrocytes. J Mol Cell Cardiol. 2013; 67:112-25. PMC: 4120952. DOI: 10.1016/j.yjmcc.2013.12.013. View

12.

Sang H, Jiang Z, Zhao Q, Xin F . MicroRNA-133a improves the cardiac function and fibrosis through inhibiting Akt in heart failure rats. Biomed Pharmacother. 2015; 71:185-9. DOI: 10.1016/j.biopha.2015.02.030. View

13.

Braz J, Gill R, Corbly A, Jones B, Jin N, Vlahos C . Selective activation of PI3Kalpha/Akt/GSK-3beta signalling and cardiac compensatory hypertrophy during recovery from heart failure. Eur J Heart Fail. 2009; 11(8):739-48. DOI: 10.1093/eurjhf/hfp094. View

14.

Taigen T, de Windt L, Lim H, Molkentin J . Targeted inhibition of calcineurin prevents agonist-induced cardiomyocyte hypertrophy. Proc Natl Acad Sci U S A. 2000; 97(3):1196-201. PMC: 15566. DOI: 10.1073/pnas.97.3.1196. View

15.

Vidigal J, Ventura A . The biological functions of miRNAs: lessons from in vivo studies. Trends Cell Biol. 2014; 25(3):137-47. PMC: 4344861. DOI: 10.1016/j.tcb.2014.11.004. View

16.

Kuwabara Y, Horie T, Baba O, Watanabe S, Nishiga M, Usami S . MicroRNA-451 exacerbates lipotoxicity in cardiac myocytes and high-fat diet-induced cardiac hypertrophy in mice through suppression of the LKB1/AMPK pathway. Circ Res. 2014; 116(2):279-88. DOI: 10.1161/CIRCRESAHA.116.304707. View

17.

Nandi S, Duryee M, Shahshahan H, Thiele G, Anderson D, Mishra P . Induction of autophagy markers is associated with attenuation of miR-133a in diabetic heart failure patients undergoing mechanical unloading. Am J Transl Res. 2015; 7(4):683-96. PMC: 4455344. View

18.

Granjon A, Gustin M, Rieusset J, Lefai E, Meugnier E, Guller I . The microRNA signature in response to insulin reveals its implication in the transcriptional action of insulin in human skeletal muscle and the role of a sterol regulatory element-binding protein-1c/myocyte enhancer factor 2C pathway. Diabetes. 2009; 58(11):2555-64. PMC: 2768160. DOI: 10.2337/db09-0165. View

19.

Yu H, Konigshoff M, Jayachandran A, Handley D, Seeger W, Kaminski N . Transgelin is a direct target of TGF-beta/Smad3-dependent epithelial cell migration in lung fibrosis. FASEB J. 2008; 22(6):1778-89. DOI: 10.1096/fj.07-083857. View

20.

Zaja I, Bai X, Liu Y, Kikuchi C, Dosenovic S, Yan Y . Cdk1, PKCδ and calcineurin-mediated Drp1 pathway contributes to mitochondrial fission-induced cardiomyocyte death. Biochem Biophys Res Commun. 2014; 453(4):710-21. PMC: 4312217. DOI: 10.1016/j.bbrc.2014.09.144. View